, /PRNewswire/ -- Caidya, a leading provider of clinical trial solutions, is proud to announce its recent accreditation in Targeted Source Data Verification (TSDV) from Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry. This accreditation marks a significant milestone in Caidya's commitment to enhancing clinical trial operations and data quality through innovative technology and strategic process optimization. has demonstrated a 33 percent decrease in monitoring days on site versus studies that do not use TSDV, according to Medidata, further empowering the adoption of advanced SDV sampling strategies and enabling clinical research associates (CRAs) to adopt a risk-based approach to monitoring, focusing on critical data – which is essential for maintaining regulatory compliance and ensuring high data integrity.
By integrating Rave TSDV, Caidya can now leverage a customized and adaptable country, site, and rule-based system that selects the Case Report Form (CRF) fields within that need verification during site visits. The clear benefit is a more efficient and cost-effective monitoring process. TSDV is at its most effective and efficient when combined with a centralized monitoring strategy, as CRA resources can be targeted based on identified anomalies and outliers, increasing or decreasing the required SDV level on a study, country, site, or trial participant level, as needed.
The Rave TSDV accreditation proc.